Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin
Status:
Completed
Trial end date:
2020-11-10
Target enrollment:
Participant gender:
Summary
This study evaluates bendamustine in patients aged over 60 years with classical Hodgkin
Lymphoma treated by prednisone, vinblastine and doxorubicin. 90 patients will be enrolled in
this study.